United States

inVentiv Health launches multichannel marketing company MySTRO

Thursday, March 8, 2012 12:34 PM

Burlington, Mass.-based inVentiv Health, which provides clinical, commercial and consulting services to the healthcare industry, has launched MySTRO, a multichannel marketing and sales solutions company. MySTRO provides sales force support, telephone and remote personal selling, print and direct mail, sample accountability and compliance services.

More... »

AmerisourceBergen to acquire World Courier

Thursday, March 8, 2012 12:31 PM

AmerisourceBergen has agreed to purchase World Courier Group, a privately held global specialty transportation and logistics provider for the biopharmaceutical industry, for $520 million in cash.

More... »

TrialAdvance launches group to target underrepresented populations in clinical trials

Thursday, March 8, 2012 12:28 PM

TrialAdvance has created a new strategy group called iDICT (Improving Disparities In Clinical Trials), aimed at helping study sponsors achieve the federal government’s directive to increase participation of underrepresented populations in clinical trials.

More... »

Ventana receives FDA clearance for Ki-67 (30-9) image analysis

Tuesday, March 6, 2012 06:06 AM

The FDA has granted Ventana Medical Systems, a member of the Roche Group, 510(k) clearance for its Ventana Companion Algorithm Ki-67 (30-9) image analysis application used with the Ventana iScan Coreo Au scanner running Virtuoso software.

More... »

OncoGenex reports promising preclinical cancer data

Monday, March 5, 2012 06:09 AM

OncoGenex Pharmaceuticals’ compound OGX-427 shows potential for augmenting anti-cancer therapies and delay tumor progression.

More... »

IOM report identifies ways to further improve pediatric studies

Friday, March 2, 2012 03:07 PM

Federal laws that motivate or require drug and biologic developers to conduct pediatric studies have yielded beneficial information to guide the use of medications in children, according to a new report by the Institute of Medicine (IOM).  Still, studies involving children continue to be limited, especially in certain areas such as medication use in newborns and long-term safety and effectiveness in children. 

More... »

Clinical Research Advantage adds clinical trials in rural Nebraska

Friday, March 2, 2012 01:39 PM

Tempe, Ariz.-based Clinical Research Advantage (CRA), a provider of research services to pharmaceutical companies and CROs, will begin offering patients throughout rural Nebraska the opportunity to participate in additional clinical trials.

More... »

Bracket joins ePRO Consortium, program of Critical Path Institute

Friday, March 2, 2012 07:07 AM

Bracket, a division of UBC, has joined the Electronic Patient-Reported Outcome (ePRO) Consortium, which seeks to improve the quality of patient reported outcomes, a crucial element in the drug development process.

More... »

Islet Sciences to acquire DiaKine Therapeutics

Friday, March 2, 2012 06:00 AM

Islet Sciences, a biotechnology company specializing in transplantation therapy for patients with diabetes, will acquire Charlottesville, Va.-based biopharmaceutical company DiaKine Therapeutics, which commercializes novel immune modulators for the treatment of diabetes and related complications.

More... »

Charles River Labs to license EMD Millipore’s TrueSpike technology

Friday, March 2, 2012 06:00 AM

EMD Millipore, the life science division of Merck based in Billerica, Mass., will partner with Charles River Laboratories to exclusively license the TrueSpike technology, which reduces protein content of virus preparations and increases predictability of validation studies.

More... »